These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 6843158)

  • 1. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
    Ina H; Yasuda I
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
    Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
    J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of blood cardioplegia to protect myocardium at lower temperatures.
    Magovern GJ; Flaherty JT; Gott VL; Bulkley BH; Gardner TJ
    Circulation; 1982 Aug; 66(2 Pt 2):I60-7. PubMed ID: 6805979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
    Krukenkamp I; Silverman N; Sorlie D; Pridjian A; Feinberg H; Levitsky S
    J Thorac Cardiovasc Surg; 1986 Jul; 92(1):56-62. PubMed ID: 3724227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
    Tachibana H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial recovery after hypothermic arrest: a comparison of oxygenated crystalloid to blood cardioplegia. The role of calcium.
    Heitmiller RF; DeBoer LW; Geffin GA; Toal KW; Fallon JT; Drop LJ; Teplick RS; O'Keefe DD; Daggett WM
    Circulation; 1985 Sep; 72(3 Pt 2):II241-53. PubMed ID: 4028363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia.
    Catinella FP; Cunningham JN; Spencer FC
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved myocardial protection by oxygenation of St. Thomas' Hospital cardioplegic solutions. Studies in the rat.
    Ledingham SJ; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1988 Jan; 95(1):103-11. PubMed ID: 3336223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
    Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
    Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of small-amplitude electrical activity on myocardial preservation in the cold potassium-arrested heart.
    Landymore RW; Marble AE; Trillo A; MacAulay M; Faulkner G; Cameron C
    J Thorac Cardiovasc Surg; 1986 May; 91(5):684-9. PubMed ID: 3702477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antegrade cardioplegic infusion with simultaneously controlled coronary sinus occlusion on preservation of regionally ischemic myocardium after acute coronary artery occlusion and reperfusion.
    Sun SC; Raza ST; Tam SK; Laurence R; Cohn LH
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):626-33. PubMed ID: 3172809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does lower systemic temperature enhance cardioplegic myocardial protection?
    Grover FL; Fewel JG; Ghidoni JJ; Trinkle JK
    J Thorac Cardiovasc Surg; 1981 Jan; 81(1):11-20. PubMed ID: 7453211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.